glp-1 gip and glucagon LY3437943, a novel triple glucagon, GIP, receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism GLP1-GIP receptor co-agonists: a promising

Wu, J., Zhou, M., Wan, Y

In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, handicapped, or mentally disabled persons, or economically or educationally disadvantaged persons

& Alvarez-Gonzalez, R

Patients with a history of eating disorders, who are pregnant or breastfeeding or have hypersensitivity to specific medications are not eligible

Over time, formulators began using them in scalp serums because the scalp is also skin, and a healthier scalp environment can support better-looking hair over the long term

Eder L, Chandran V, Cook R, Gladman DD